Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

2seventy bio, Inc. - Common Stock (NQ:TSVT)

4.970 +0.010 (+0.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,209,030
Open 4.950
Bid (Size) 4.960 (3)
Ask (Size) 4.970 (7)
Prev. Close 4.960
Today's Range 4.950 - 4.970
52wk Range 2.290 - 5.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results
From 2seventy bio, Inc.
Via Business Wire
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+67.9%
+67.9%
1 Month
+91.2%
+91.2%
3 Month
+67.9%
+67.9%
6 Month
+4.6%
+4.6%
1 Year
-0.2%
-0.2%

More News

Read More
Unusual volume stocks are being observed in Wednesday's session.
Via Chartmill
Earnings Scheduled For November 12, 2024
Via Benzinga
2seventy bio Earnings Preview
Via Benzinga
Shareholder Alert: The Ademi Firm investigates whether 2seventy bio, Inc. is obtaining a Fair Price for its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
Tuesday's session: top gainers and losers
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
From Brodsky & Smith LLC
Via GlobeNewswire
Gapping stocks in Tuesday's session
Via Chartmill
Crude Oil Gains 1%; Ciena Earnings Top Views
Via Benzinga
Exposures Fossil Fuels
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
Via Benzinga
US Stocks Mixed; Kohl's Shares Plunge After Q4 Results
Via Benzinga
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
Top 3 Health Care Stocks That May Keep You Up At Night In Q1
Via Benzinga
TSVT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of 2seventy bio, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Via Benzinga
US Stocks Likely To Open Higher After Monday's Selloff: TSLA Stock Rebounds From Its Worst Fall In 5 Years After Trump Backs Musk, Analyst Says 'Pullbacks Are Normal'
Via Benzinga
Topics Government
Exposures Political
2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb
From 2seventy bio, Inc.
Via Business Wire
2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference
From 2seventy bio, Inc.
Via Business Wire
Novo Nordisk Eyes 2025 Regulatory Filing For Hemophilia Candidate After Encouraging Pediatric Study Data
Via Benzinga
2seventy bio Reports Preliminary* Full-Year U.S. Abecma Sales and Select Financial Results
From 2seventy bio, Inc.
Via Business Wire
2seventy bio Reports Third Quarter Financial Results and Recent Operational Progress
From 2seventy bio, Inc.
Via Business Wire
2seventy bio to Report Third Quarter 2024 Financial Results and Participate in Upcoming Investor Conference
From 2seventy bio, Inc.
Via Business Wire
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia Drug
Via Benzinga

Frequently Asked Questions

Is 2seventy bio, Inc. - Common Stock publicly traded?
Yes, 2seventy bio, Inc. - Common Stock is publicly traded.
What exchange does 2seventy bio, Inc. - Common Stock trade on?
2seventy bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for 2seventy bio, Inc. - Common Stock?
The ticker symbol for 2seventy bio, Inc. - Common Stock is TSVT on the Nasdaq Stock Market
What is the current price of 2seventy bio, Inc. - Common Stock?
The current price of 2seventy bio, Inc. - Common Stock is 4.970
When was 2seventy bio, Inc. - Common Stock last traded?
The last trade of 2seventy bio, Inc. - Common Stock was at 04/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.